Betticher D - Search Results

1

A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer.

Pless M, Droege C, von Moos R, Salzberg M, Betticher D. Pless M, et al. Among authors: betticher d. Lung Cancer. 2013 Sep;81(3):445-450. doi: 10.1016/j.lungcan.2013.06.025. Epub 2013 Jul 23. Lung Cancer. 2013. PMID: 23891283 Clinical Trial.

2

[Pneumocystis carinii pneumonia during therapy with 2-chlorodeoxyadenosine (2-CDA)].

Haberthür C, Pless M, Tichelli A, Gratwohl A, Speck B, Betticher DC. Haberthür C, et al. Among authors: betticher dc. Schweiz Med Wochenschr. 1994 Jan 11;124(1-2):73-8. Schweiz Med Wochenschr. 1994. PMID: 7905206 German.

3

G1 control gene status is frequently altered in resectable non-small cell lung cancer.

Betticher DC, White GR, Vonlanthen S, Liu X, Kappeler A, Altermatt HJ, Thatcher N, Heighway J. Betticher DC, et al. Int J Cancer. 1997 Oct 21;74(5):556-62. doi: 10.1002/(sici)1097-0215(19971021)74:5<556::aid-ijc14>3.0.co;2-4. Int J Cancer. 1997. PMID: 9355981 Free article.

4

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.

Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC, Betticher DC. Borner MM, et al. Among authors: betticher dc. Br J Cancer. 1999 Feb;79(5-6):952-8. doi: 10.1038/sj.bjc.6690152. Br J Cancer. 1999. PMID: 10070896 Free PMC article.

5

Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.

Gugger M, Kappeler A, Vonlanthen S, Altermatt HJ, Ris HB, Lardinois D, Borner MM, Heighway J, Betticher DC. Gugger M, et al. Among authors: betticher dc. Lung Cancer. 2001 Aug-Sep;33(2-3):229-39. doi: 10.1016/s0169-5002(01)00196-9. Lung Cancer. 2001. PMID: 11551418

6

Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.

Calderoni A, von Briel C, Aebi S, Solenthaler M, Betticher DC. Calderoni A, et al. Lung Cancer. 2002 Jun;36(3):321-6. doi: 10.1016/s0169-5002(01)00487-1. Lung Cancer. 2002. PMID: 12009245 Clinical Trial.

7

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

Betticher DC, Hsu Schmitz SF, Tötsch M, Hansen E, Joss C, von Briel C, Schmid RA, Pless M, Habicht J, Roth AD, Spiliopoulos A, Stahel R, Weder W, Stupp R, Egli F, Furrer M, Honegger H, Wernli M, Cerny T, Ris HB. Betticher DC, et al. J Clin Oncol. 2003 May 1;21(9):1752-9. doi: 10.1200/JCO.2003.11.040. J Clin Oncol. 2003. PMID: 12721251 Clinical Trial.

8

Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer.

Betticher DC, Rosell R. Betticher DC, et al. Lung Cancer. 2004 Dec;46 Suppl 2:S23-32. doi: 10.1016/s0169-5002(04)80038-2. Lung Cancer. 2004. PMID: 15698528 Review.

9

Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.

Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers NL, Ratschiller D, Jermann M, Stahel RA, Heighway J, Betticher DC. Gautschi O, et al. Among authors: betticher dc. Lung Cancer. 2006 Mar;51(3):303-11. doi: 10.1016/j.lungcan.2005.10.025. Epub 2006 Jan 10. Lung Cancer. 2006. PMID: 16406195

10

Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.

Betticher DC. Betticher DC. Lung Cancer. 2005 Dec;50 Suppl 2:S9-16. Lung Cancer. 2005. PMID: 16557669 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page